WILLIAMS AND JENSEN, PLLC
Lobbying for BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.) · Healthcare/Pharmaceuticals
Monitor progress of next Prescription Drug User Fee Reauthorization, issues relating to US and international manufacturing, oncology issues, FDA reorganization and programs, 340B, monitoring efforts around direct-to-consumer policies.
Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues.
Issues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing), access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.
Monitoring efforts to onshore and build US pharmaceutical manufacturing capacity.
H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.